158 related articles for article (PubMed ID: 29805636)
1. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9.
Hua Y; Liang C; Miao C; Wang S; Su S; Shao P; Liu B; Bao M; Zhu J; Xu A; Zhang J; Li J; Wang Z
Oncol Lett; 2018 Jun; 15(6):9051-9060. PubMed ID: 29805636
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
3. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
[TBL] [Abstract][Full Text] [Related]
4. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
6. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
7. The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.
Chang AC; Lin LW; Chen YC; Chen PC; Liu SC; Tai HC; Wu HC; Sung SY; Lin TH; Tang CH
Int J Biol Sci; 2023; 19(3):760-771. PubMed ID: 36778124
[No Abstract] [Full Text] [Related]
8. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-195 inhibits proliferation and metastasis in renal cell carcinoma via regulating HMGA1.
Dong H; Sun S; Yan T; Liang C; Zhu J; Miao C; Qin C; Shao P; Wang Z; Li J; Li P
Am J Transl Res; 2020; 12(6):2781-2792. PubMed ID: 32655809
[TBL] [Abstract][Full Text] [Related]
11. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9.
Yang X; Cui Y; Yang F; Sun C; Gao X
Mol Med Rep; 2017 Sep; 16(3):3565-3572. PubMed ID: 28713950
[TBL] [Abstract][Full Text] [Related]
13. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
Goto Y; Kojima S; Kurozumi A; Kato M; Okato A; Matsushita R; Ichikawa T; Seki N
Br J Cancer; 2016 May; 114(10):1135-44. PubMed ID: 27070713
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.
Qin C; Zhao Y; Gong C; Yang Z
Oncol Lett; 2017 Dec; 14(6):6969-6975. PubMed ID: 29163713
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9.
Jiang L; Liu Y; Ma C; Li B
Oncol Lett; 2018 Sep; 16(3):3038-3044. PubMed ID: 30127894
[TBL] [Abstract][Full Text] [Related]
16. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP
Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA ADAM9 facilitates the malignant behaviours of pancreatic cancer by sponging miR-217 and upregulating PRSS3 expression.
Xing C; Ye H; Wang W; Sun M; Zhang J; Zhao Z; Jiang G
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3920-3928. PubMed ID: 31810373
[TBL] [Abstract][Full Text] [Related]
18. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
19. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
